These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3553029)

  • 1. Screening for anti-HTLV-III/LAV antibody in high-risk subjects: sensitivity and specificity of commercial tests.
    Lantin JP; Peitrequin R; Frei PC
    Int Arch Allergy Appl Immunol; 1987; 82(3-4):487-9. PubMed ID: 3553029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How sensitive are the commercial assays for anti-HTLV III/LAV?
    Oldham LJ; Moulsdale HJ; Mortimer PP; Tedder RS; Morgan-Capner P
    J Med Virol; 1987 Jan; 21(1):75-9. PubMed ID: 3467026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitivity and specificity of commercial ELISA kits for screening anti-LAV/HTLV III.
    Gürtler LG; Eberle J; Lorbeer B; Deinhardt F
    J Virol Methods; 1987 Jan; 15(1):11-23. PubMed ID: 3468119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of antibodies against LAV/HTLV III: comparative evaluation of four different commercial test kits.
    Abb J
    AIDS Res; 1986; 2(2):93-7. PubMed ID: 3013224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of two ELISA kits for the demonstration of antibodies against LAV/HTLV-III].
    Heinz FX; Kunz C; Barrett N
    Zentralbl Bakteriol Mikrobiol Hyg A; 1987 Apr; 264(1-2):196-200. PubMed ID: 3307232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of acquired immunodeficiency syndrome (AIDS) retrovirus antibody by lymphadenopathy-associated virus (LAV) enzyme immunoassay in low- and high-risk populations.
    Ragni MV; Lewis JH; Bracken M; Toth R; Stokes J; Steffensen DO
    Transfusion; 1986; 26(3):299-301. PubMed ID: 3010516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of 3 immuno-enzyme kits for the detection of anti-LAV antibodies. Comparison with confirmation tests. Study Subgroup of the National Blood Transfusion Society].
    Rev Fr Transfus Immunohematol; 1985 Sep; 28(4):325-44. PubMed ID: 3001897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of EIA kits for the detection of HIV antibodies.
    Ovcak S; Drinovec B; Likar M
    Acta Virol; 1987 Sep; 31(5):434-8. PubMed ID: 2891282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [HIV (HTLV III/LAV) serology: experiences based on more than 42,000 tests].
    Gschnait F; Schmidt BL; Schwarz T; Heinz FX; Kunz C
    Wien Klin Wochenschr; 1987 Aug; 99(15):536-9. PubMed ID: 3310415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of HTLV-III antibody in cerebrospinal fluid from patients with AIDS and pre-AIDS with the use of a commercial test system.
    Johnson JE; Zolla-Pazner S
    Am J Clin Pathol; 1987 Sep; 88(3):351-3. PubMed ID: 3477084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Western blot (immunoblot) based on recombinant-derived p41 with conventional tests for serodiagnosis of human immunodeficiency virus infections.
    Hofbauer JM; Schulz TF; Hengster P; Larcher C; Zangerle R; Kofler H; Fritsch P; Wachter H; Dierich MP
    J Clin Microbiol; 1988 Jan; 26(1):116-20. PubMed ID: 3277988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of enzyme immunoassays and an immunofluorescence test for detection of antibody to human immunodeficiency virus in African sera.
    Vercauteren G; van der Groen G; Piot P
    Eur J Clin Microbiol; 1987 Apr; 6(2):132-5. PubMed ID: 3297680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human immunodeficiency virus antibody screening in blood donors from India, Nigeria and Thailand.
    Kühnl P; Seidl S; Ray V; Kulkarni AG; Mba EC; Chandanayingyong D
    Vox Sang; 1987; 52(3):203-5. PubMed ID: 3300027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of human immunodeficiency virus (HIV) type 1 and 2 recombinant strip immunoblot assay to resolve enzyme immunoassay anti-HIV-2-repeatably reactive samples after anti-HIV-1/2 combination enzyme immunoassay screening.
    Tobler LH; Kaufman E; Gefter N; Schable C; Busch MP
    Transfusion; 1997 Sep; 37(9):921-5. PubMed ID: 9308638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance evaluation of the Abbott HTLV III EIA, a test for antibody to HTLV III in donor blood.
    Barrett JE; Dawson G; Heller J; Bairstow C; Fico R; Webber JS; Gutierrez R; Decker RH
    Am J Clin Pathol; 1986 Aug; 86(2):180-5. PubMed ID: 3017089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of two commercially available anti-HIV ELISAs: Abbott HTLV III EIA and Du Pont HTLV III-ELISA.
    Burkhardt U; Mertens T; Eggers HJ
    J Med Virol; 1987 Nov; 23(3):217-24. PubMed ID: 3323415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Summary of the Centers for Disease Control human immunodeficiency virus (HIV) performance evaluation surveys for 1985 and 1986.
    Taylor RN; Przybyszewski VA
    Am J Clin Pathol; 1988 Jan; 89(1):1-13. PubMed ID: 3276137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Value of ELISA in the diagnosis of HTLV-III-LAV infection. Specificity of kits].
    Lazizi Y; Guetard D; Pillot J
    Presse Med; 1986 Dec; 15(43):2169. PubMed ID: 2954072
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of an enzyme immunoassay for detection of antibody to human immunodeficiency virus in low risk populations.
    Peetoom F
    Transfusion; 1986; 26(6):536-8. PubMed ID: 3535179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening and confirmatory tests for antibody to HTLV-III/LAV retrovirus in individuals at risk for AIDS.
    De Majo E; Ravina A; Ricciarelli L; Parri F; Mazzetti M; Di Pietro M; Colao MG; Milo D; Romagnani S
    Ric Clin Lab; 1986; 16(3):489-94. PubMed ID: 3544160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.